Medical Care

Global Autologous CAR-T Cell Therapy Market Research Report 2025

The global market for Autologous CAR-T Cell Therapy was valued at US$ 4437 million in the year 2024 and is projected to reach a revised size of US$ 17630 million by 2031, growing at a CAGR of 22.1% during the forecast period.
CAR-T cell therapy is a novel immunotherapy method, abbreviated as chimeric antigen receptor T cells. Autologous CAR-T cell therapy uses the patient's own T cells, which are genetically engineered to express a specific receptor, thereby enhancing their ability to target tumor cells.
Cell immunotherapy techniques, represented by chimeric antigen receptor T-cell immunotherapy (CAR-T therapy), express CAR fusion proteins on the surface of T cells through genetic engineering technology. The CAR extracellular antigen recognition region (one of the components of CAR cells, responsible for recognizing tumor cell surface antigens) can specifically recognize tumor antigens and transmit signals into cells to activate T cells, achieving proliferation and targeted killing of tumor cells. CAR-T therapy has shown breakthrough efficacy and enormous potential for development and market prospects for cancer patients who are unable to cope with traditional treatments. CAR-T cells are divided into autologous and allogeneic CAR-T cells. At present, CAR-T therapy mainly uses autologous CAR-T cells.
In recent years, the progress of autologous CAR-T cell therapy in hematological tumors has inspired scientists to extend this technology to the treatment of solid tumors. However, the current progress in the treatment of solid tumors is relatively slow. But in the future, with the discovery of more targets and the development of clinical trials, solid tumors are expected to become the main treatment area for CAR-T. At present, JW (Cayman) Therapeutics is laying out more innovative products to officially enter the field of cell therapy for solid tumors.
This report aims to provide a comprehensive presentation of the global market for Autologous CAR-T Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous CAR-T Cell Therapy.
The Autologous CAR-T Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autologous CAR-T Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autologous CAR-T Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Gilead (Kite Pharma)
Bristol Myers Squibb
Fosun Kite Biotechnology
JW Therapeutics
Bluebird Bio
IASO Bio
Juventas Cell Therapy
Legend Biotech
CARsge
Segment by Type
Target: CD19
Target: BCMA
Segment by Application
Hematological Tumors
Solid Tumor
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autologous CAR-T Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous CAR-T Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Target: CD19
1.2.3 Target: BCMA
1.3 Market by Application
1.3.1 Global Autologous CAR-T Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hematological Tumors
1.3.3 Solid Tumor
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autologous CAR-T Cell Therapy Market Perspective (2020-2031)
2.2 Global Autologous CAR-T Cell Therapy Growth Trends by Region
2.2.1 Global Autologous CAR-T Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Autologous CAR-T Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Autologous CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Autologous CAR-T Cell Therapy Market Dynamics
2.3.1 Autologous CAR-T Cell Therapy Industry Trends
2.3.2 Autologous CAR-T Cell Therapy Market Drivers
2.3.3 Autologous CAR-T Cell Therapy Market Challenges
2.3.4 Autologous CAR-T Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autologous CAR-T Cell Therapy Players by Revenue
3.1.1 Global Top Autologous CAR-T Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Autologous CAR-T Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top Autologous CAR-T Cell Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Autologous CAR-T Cell Therapy Revenue
3.4 Global Autologous CAR-T Cell Therapy Market Concentration Ratio
3.4.1 Global Autologous CAR-T Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous CAR-T Cell Therapy Revenue in 2024
3.5 Global Key Players of Autologous CAR-T Cell Therapy Head office and Area Served
3.6 Global Key Players of Autologous CAR-T Cell Therapy, Product and Application
3.7 Global Key Players of Autologous CAR-T Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous CAR-T Cell Therapy Breakdown Data by Type
4.1 Global Autologous CAR-T Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Autologous CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Autologous CAR-T Cell Therapy Breakdown Data by Application
5.1 Global Autologous CAR-T Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Autologous CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Autologous CAR-T Cell Therapy Market Size (2020-2031)
6.2 North America Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)
6.4 North America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autologous CAR-T Cell Therapy Market Size (2020-2031)
7.2 Europe Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autologous CAR-T Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Autologous CAR-T Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autologous CAR-T Cell Therapy Market Size (2020-2031)
9.2 Latin America Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autologous CAR-T Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Autologous CAR-T Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Autologous CAR-T Cell Therapy Introduction
11.1.4 Novartis Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Gilead (Kite Pharma)
11.2.1 Gilead (Kite Pharma) Company Details
11.2.2 Gilead (Kite Pharma) Business Overview
11.2.3 Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Introduction
11.2.4 Gilead (Kite Pharma) Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.2.5 Gilead (Kite Pharma) Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb Autologous CAR-T Cell Therapy Introduction
11.3.4 Bristol Myers Squibb Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Fosun Kite Biotechnology
11.4.1 Fosun Kite Biotechnology Company Details
11.4.2 Fosun Kite Biotechnology Business Overview
11.4.3 Fosun Kite Biotechnology Autologous CAR-T Cell Therapy Introduction
11.4.4 Fosun Kite Biotechnology Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.4.5 Fosun Kite Biotechnology Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Autologous CAR-T Cell Therapy Introduction
11.5.4 JW Therapeutics Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.5.5 JW Therapeutics Recent Development
11.6 Bluebird Bio
11.6.1 Bluebird Bio Company Details
11.6.2 Bluebird Bio Business Overview
11.6.3 Bluebird Bio Autologous CAR-T Cell Therapy Introduction
11.6.4 Bluebird Bio Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.6.5 Bluebird Bio Recent Development
11.7 IASO Bio
11.7.1 IASO Bio Company Details
11.7.2 IASO Bio Business Overview
11.7.3 IASO Bio Autologous CAR-T Cell Therapy Introduction
11.7.4 IASO Bio Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.7.5 IASO Bio Recent Development
11.8 Juventas Cell Therapy
11.8.1 Juventas Cell Therapy Company Details
11.8.2 Juventas Cell Therapy Business Overview
11.8.3 Juventas Cell Therapy Autologous CAR-T Cell Therapy Introduction
11.8.4 Juventas Cell Therapy Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.8.5 Juventas Cell Therapy Recent Development
11.9 Legend Biotech
11.9.1 Legend Biotech Company Details
11.9.2 Legend Biotech Business Overview
11.9.3 Legend Biotech Autologous CAR-T Cell Therapy Introduction
11.9.4 Legend Biotech Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.9.5 Legend Biotech Recent Development
11.10 CARsge
11.10.1 CARsge Company Details
11.10.2 CARsge Business Overview
11.10.3 CARsge Autologous CAR-T Cell Therapy Introduction
11.10.4 CARsge Revenue in Autologous CAR-T Cell Therapy Business (2020-2025)
11.10.5 CARsge Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Autologous CAR-T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Target: CD19
Table 3. Key Players of Target: BCMA
Table 4. Global Autologous CAR-T Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Autologous CAR-T Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Autologous CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Autologous CAR-T Cell Therapy Market Share by Region (2020-2025)
Table 8. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Autologous CAR-T Cell Therapy Market Share by Region (2026-2031)
Table 10. Autologous CAR-T Cell Therapy Market Trends
Table 11. Autologous CAR-T Cell Therapy Market Drivers
Table 12. Autologous CAR-T Cell Therapy Market Challenges
Table 13. Autologous CAR-T Cell Therapy Market Restraints
Table 14. Global Autologous CAR-T Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Autologous CAR-T Cell Therapy Market Share by Players (2020-2025)
Table 16. Global Top Autologous CAR-T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous CAR-T Cell Therapy as of 2024)
Table 17. Ranking of Global Top Autologous CAR-T Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Autologous CAR-T Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Autologous CAR-T Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Autologous CAR-T Cell Therapy, Product and Application
Table 21. Global Key Players of Autologous CAR-T Cell Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Autologous CAR-T Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Autologous CAR-T Cell Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Autologous CAR-T Cell Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Autologous CAR-T Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Autologous CAR-T Cell Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Autologous CAR-T Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Autologous CAR-T Cell Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Autologous CAR-T Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Autologous CAR-T Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Autologous CAR-T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Autologous CAR-T Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novartis Company Details
Table 47. Novartis Business Overview
Table 48. Novartis Autologous CAR-T Cell Therapy Product
Table 49. Novartis Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Gilead (Kite Pharma) Company Details
Table 52. Gilead (Kite Pharma) Business Overview
Table 53. Gilead (Kite Pharma) Autologous CAR-T Cell Therapy Product
Table 54. Gilead (Kite Pharma) Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 55. Gilead (Kite Pharma) Recent Development
Table 56. Bristol Myers Squibb Company Details
Table 57. Bristol Myers Squibb Business Overview
Table 58. Bristol Myers Squibb Autologous CAR-T Cell Therapy Product
Table 59. Bristol Myers Squibb Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 60. Bristol Myers Squibb Recent Development
Table 61. Fosun Kite Biotechnology Company Details
Table 62. Fosun Kite Biotechnology Business Overview
Table 63. Fosun Kite Biotechnology Autologous CAR-T Cell Therapy Product
Table 64. Fosun Kite Biotechnology Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 65. Fosun Kite Biotechnology Recent Development
Table 66. JW Therapeutics Company Details
Table 67. JW Therapeutics Business Overview
Table 68. JW Therapeutics Autologous CAR-T Cell Therapy Product
Table 69. JW Therapeutics Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 70. JW Therapeutics Recent Development
Table 71. Bluebird Bio Company Details
Table 72. Bluebird Bio Business Overview
Table 73. Bluebird Bio Autologous CAR-T Cell Therapy Product
Table 74. Bluebird Bio Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 75. Bluebird Bio Recent Development
Table 76. IASO Bio Company Details
Table 77. IASO Bio Business Overview
Table 78. IASO Bio Autologous CAR-T Cell Therapy Product
Table 79. IASO Bio Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 80. IASO Bio Recent Development
Table 81. Juventas Cell Therapy Company Details
Table 82. Juventas Cell Therapy Business Overview
Table 83. Juventas Cell Therapy Autologous CAR-T Cell Therapy Product
Table 84. Juventas Cell Therapy Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 85. Juventas Cell Therapy Recent Development
Table 86. Legend Biotech Company Details
Table 87. Legend Biotech Business Overview
Table 88. Legend Biotech Autologous CAR-T Cell Therapy Product
Table 89. Legend Biotech Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 90. Legend Biotech Recent Development
Table 91. CARsge Company Details
Table 92. CARsge Business Overview
Table 93. CARsge Autologous CAR-T Cell Therapy Product
Table 94. CARsge Revenue in Autologous CAR-T Cell Therapy Business (2020-2025) & (US$ Million)
Table 95. CARsge Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report


List of Figures
Figure 1. Autologous CAR-T Cell Therapy Picture
Figure 2. Global Autologous CAR-T Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Autologous CAR-T Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. Target: CD19 Features
Figure 5. Target: BCMA Features
Figure 6. Global Autologous CAR-T Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Autologous CAR-T Cell Therapy Market Share by Application: 2024 VS 2031
Figure 8. Hematological Tumors Case Studies
Figure 9. Solid Tumor Case Studies
Figure 10. Autologous CAR-T Cell Therapy Report Years Considered
Figure 11. Global Autologous CAR-T Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Autologous CAR-T Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Autologous CAR-T Cell Therapy Market Share by Region: 2024 VS 2031
Figure 14. Global Autologous CAR-T Cell Therapy Market Share by Players in 2024
Figure 15. Global Autologous CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Autologous CAR-T Cell Therapy Revenue in 2024
Figure 17. North America Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 19. United States Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 23. Germany Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Autologous CAR-T Cell Therapy Market Share by Region (2020-2031)
Figure 31. China Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 39. Mexico Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Autologous CAR-T Cell Therapy Market Share by Country (2020-2031)
Figure 43. Turkey Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Autologous CAR-T Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 47. Gilead (Kite Pharma) Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 48. Bristol Myers Squibb Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 49. Fosun Kite Biotechnology Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 50. JW Therapeutics Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 51. Bluebird Bio Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 52. IASO Bio Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 53. Juventas Cell Therapy Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 54. Legend Biotech Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 55. CARsge Revenue Growth Rate in Autologous CAR-T Cell Therapy Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies